Johnson & Johnson in Collaboration with Apple Launch Heartline Study App in the US

 Johnson & Johnson in Collaboration with Apple Launch Heartline Study App in the US

Johnson & Johnson in Collaboration with Apple Launch Heartline Study App in the US

Shots:

  • The study will assess the Heartline study app on iPhone, the ECG app and irregular rhythm notification feature on Apple Watch in improving the health outcomes including reduction in risk of stroke with earlier detection of AFib
  • The companies offer US adults aged ≥65yrs. having an iPhone 6s or later version to join the study by downloading the Heartline study app. The heartline study will assess people for 3yrs. which includes 2yrs. of active engagement & 1yrs. of additional data collection
  • In the study, one group of patients will use the Heartline study app on their iPhone and other groups will use the study app in addition to obtaining an Apple Watch to use the ECG app and irregular rhythm notification feature. The Heartline Study app will identify any suspected AFib rhythms and notify users when that happens

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Baaz

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post